InvestorsHub on MSN
BioCardia shares rally after FDA supports regulatory path for heart failure therapy (BCDA)
BioCardia Inc. (NASDAQ:BCDA) shares surged 26.2% in premarket trading on Friday after the company announced that the U.S.
A heart attack is far from an isolated, acute event. The consequences of an attack can cause serious and lasting damage, ...
A heart attack is far from being an isolated, acute event. The consequences of an attack can cause serious and lasting damage ...
For people with advanced heart failure, left ventricular assist devices, or LVADs, can be a literal lifesaver. The implantable devices, which improve blood flow throughout the body, are often the last ...
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and ...
Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult ...
A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...
Diastolic heart failure means there’s a problem with your heart’s ability to fill with blood. It’s a type of congestive heart failure where your heart cannot work efficiently, leading to fluid ...
These two conditions affect how well your heart can pump blood. Cardiomyopathy can sometimes lead to heart failure. Cardiomyopathy and heart failure are both conditions in which your heart has a more ...
Heart failure is when the heart does not pump enough blood around the body. Biventricular heart failure is when chambers on both sides of the heart, known as ventricles, are affected. Doctors classify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results